Abstract:Streptomyces sp. PAL 114, is an actinobacterium isolated from Saharan soil. This strain was previously shown to produce various angucyclines-type antibiotics. This class of molecule, exclusively produced by actinobacteria strains, displays a broad range of biological activities. Among bioactivities, the quest for potential suppressors of oxidative stress-associated disorders remains a priority goal for therapeutic researchers. In this study, during feeding experiments, the bacterium was able to synthesize a new compound after the addition of histidine, leucine, proline or tyrosine as a sole nitrogen source, in a starch-amended synthetic broth. After purification and analyses, the compound was identified as rabelomycin. As an anthraquinone, induced rabelomycin exhibited an anti-Gram-positive oriented antimicrobial spectrum with appreciable MIC values ranging from 5 to 80 μg/ml. The molecule also showed moderate cytotoxic activity against Caco-2 cells, with IC50 values of 31.27 μM. In fact, at 10 μM X1 54% of 24 h-exposed Caco-2 cells were viable while exposure to the same concentration of vineomycin A1, as toxic control, resulted in less than 3% living cells. By evaluating DPPH scavenging activity, the assay reveals, for the first time, the significant antioxidant activity of rabelomycin, which represent 50% of the potential expressed by the reference ascorbic acid) (IC50 = 70.37 μg/ml). Furthermore, density functional theory (DFT) calculations at the CAM-B3LYP with 6-311G + (d, p) level were performed to further decipher the intrinsic characteristics of rabelomycin and how they relate to the experimental results. The main working mechanism, homolytic hydrogen atom transfer (HAT), was considered, and the O–H bond dissociation free energy (BDFE) was calculated. The theoretical results show the effect of the substituent position with respect to the phenolic O–H group on reactivity. Various reactivity descriptors have been calculated to evaluate the reactivity of the compounds.

Structure-Activity Relationship Studies of the Peptide Antibiotic Clovibactin

Correction to "Structure-Activity Relationship Studies of the Peptide Antibiotic Clovibactin"

Synthesis and structure-activity study of the antimicrobial lipopeptide brevibacillin

Chemical Synthesis and Biological Activity of Analogues of the Lantibiotic Epilancin 15X

Establishing the Comprehensive Structure−Activity Relationship of the Natural Antibiotic Kibdelomycin/Amycolamicin

Structure-Activity Relationships of the Antimicrobial Peptide Natural Product Apidaecin

Exploring Structure-Activity Relationships and Modes of Action of Laterocidine

An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria

Diversity-oriented synthesis of cyclic acyldepsipeptides leads to the discovery of a potent antibacterial agent

A novel tricyclic β-lactam exhibiting potent antibacterial activities against carbapenem-resistant Enterobacterales: Synthesis and structure-activity-relationships

Enzymatic Synthesis of a Polyketide/Nonribosomal Peptide Hybrid Antibiotic, Salivabactin

An antibiotic from an uncultured bacterium binds to an immutable target

On-resin Cyclization and Antimicrobial Activity of Laterocidin and Its Analogues

Newly Streptomyces-Induced Rabelomycin after Specific Amino Acid Supplementations: Experimental and Computational Investigations of Reactivities

Total Synthesis and Structural Reassignment of the Antitubercular Natural Product Evybactin

Studies on Nonconventionally Fused Bicyclic Β-Lactams

A new antibiotic from an uncultured bacterium binds to an immutable target

Synthesis and structure-activity relationships of teixobactin

TAG‐Assisted Liquid‐Phase Synthesis and Structure Activity Relationship of Macolacin‐Based Side‐to‐Tail Cyclopeptides Antibiotic

Optimization of the Central α-Amino Acid in Cystobactamids to the Broad-Spectrum, Resistance-Breaking Antibiotic CN-CC-861

Studies On Nonconventionally Fused Bicyclic Beta-Lactams